ReviewChildhood kidney diseases2026
Microbiome and metabolomics insights into pediatric urinary tract infection: a narrative review.
Review in Childhood kidney diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urinary tract infections (UTIs) are among the most common bacterial infections in infants and a significant cause of antibiotic exposure. Recent advances in culture-independent sequencing and improved urine culture techniques have revealed that urine contains resident microbial communities, collectively known as the urinary microbiome (urobiome). Additionally, emerging evidence supports the existence of a gut-bladder axis, where intestinal dysbiosis may lead to uropathogen colonization, immune modulation, and UTI recurrence. This review summarizes current pediatric research connecting alterations in the urinary and gut microbiomes to UTI susceptibility, recurrence, and clinical outcomes, specifically in infants. We also address the unique methodological challenges in pediatric urobiome research and outline future directions for applying microbiome and metabolomics insights to clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.